IKZF1 and Miyoshi myopathy: On the other hand, identification of Ikaros and Aiolos gene targets is relevant to better delineate the therapeutic effects of IMiDs as well as to design new pharmacologic agents to achieve better efficacy and overcome IMiDs resistance, one of the major complications in MM therapy.